All In MedTech

Device Trial Radar · NCT06784063

Visual Performance With Clareon® Vivity® Intraocular Lenses (IOLs)

Evaluation of the Impact of Residual Astigmatism on the Visual Performance With Clareon Vivity

Last checked: Nov 20, 2026Latest source record: Jul 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

40

Actual

Start

Apr 10, 2025

Primary completion

Jun 13, 2025

Study completion Jun 13, 2025

Sponsor

Lead sponsor
Alcon ResearchNot on our public-company list
Sponsor type
Industry
First posted
Jan 20, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 22 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to generate clinical data to quantify the impact of residual astigmatism on the overall visual performance during distance, intermediate, and near viewing in patients implanted with Clareon Vivity IOLs.

Conditions

  • Astigmatism

Interventions

  • Clareon Vivity Extended Vision IOLDevice

    Extended vision intraocular lens implanted in the capsular bag of the eye during cataract surgery. IOLs are intended for long term use over the lifetime of the cataract patient.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean Difference in Monocular Best Corrected Distance Visual Acuity (BCDVA) (4 Meters) Before and After Inducing 1.0 Diopter (D) Astigmatism - WTRTime frame: Day 0 before induced astigmatism; Day 0 after induced astigmatism
  2. Mean Difference in Monocular Distance Corrected Intermediate Visual Acuity (DCIVA) (66 Centimeters) Before and After Inducing 1.0 D Astigmatism - WTRTime frame: Day 0 before induced astigmatism; Day 0 after induced astigmatism
  3. Mean Difference in Monocular Distance Corrected Near Visual Acuity (DCNVA) (40 cm) Before and After Inducing 1.0 D Astigmatism - WTRTime frame: Day 0 before induced astigmatism; Day 0 after induced astigmatism

3 more outcomes with a free account

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Grosinger, Spigelman & Grey Eye Surgeons, P.C

    Bloomfield Hills, Michigan

  • Key-Whitman Eye Center

    Dallas, Texas

  • Berkeley Eye Center

    Sugar Land, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.